Company’s 36-month beta value is 2.18.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 1 as “sell.”
The public float for DHC is 215.75M, and currently, short sellers hold a 2.96% ratio of that floaft. The average trading volume of DHC on November 15, 2024 was 1.04M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
DHC) stock’s latest price update
Diversified Healthcare Trust (NASDAQ: DHC)’s stock price has decreased by -3.52 compared to its previous closing price of 2.56. However, the company has seen a -7.84% decrease in its stock price over the last five trading sessions. benzinga.com reported 2024-11-11 that The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.
DHC’s Market Performance
Diversified Healthcare Trust (DHC) has experienced a -7.84% fall in stock performance for the past week, with a -34.83% drop in the past month, and a -22.08% drop in the past quarter. The volatility ratio for the week is 6.22%, and the volatility levels for the past 30 days are at 6.37% for DHC. The simple moving average for the last 20 days is -22.19% for DHC stock, with a simple moving average of -17.50% for the last 200 days.
Analysts’ Opinion of DHC
Many brokerage firms have already submitted their reports for DHC stocks, with Wells Fargo repeating the rating for DHC by listing it as a “Underweight.” The predicted price for DHC in the upcoming period, according to Wells Fargo is $4 based on the research report published on December 10, 2020 of the previous year 2020.
Wells Fargo gave a rating of “Equal Weight” to DHC, setting the target price at $9 in the report published on January 17th of the previous year.
DHC Trading at -29.28% from the 50-Day Moving Average
After a stumble in the market that brought DHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.75% of loss for the given period.
Volatility was left at 6.37%, however, over the last 30 days, the volatility rate increased by 6.22%, as shares sank -33.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.23% lower at present.
During the last 5 trading sessions, DHC fell by -7.84%, which changed the moving average for the period of 200-days by -13.94% in comparison to the 20-day moving average, which settled at $3.17. In addition, Diversified Healthcare Trust saw -33.96% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DHC starting from Brown Matthew C., who purchase 2,000 shares at the price of $2.55 back on Nov 13 ’24. After this action, Brown Matthew C. now owns 86,282 shares of Diversified Healthcare Trust, valued at $5,098 using the latest closing price.
Stock Fundamentals for DHC
Current profitability levels for the company are sitting at:
- 0.44 for the present operating margin
- 0.56 for the gross margin
The net margin for Diversified Healthcare Trust stands at -0.15. The total capital return value is set at 0.22. Equity return is now at value -17.17, with -7.13 for asset returns.
Based on Diversified Healthcare Trust (DHC), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.03. The debt to equity ratio resting at 1.44. The interest coverage ratio of the stock is 5.12.
Currently, EBITDA for the company is 203.19 million with net debt to EBITDA at 14.63. When we switch over and look at the enterprise to sales, we see a ratio of 1.25.
Conclusion
In a nutshell, Diversified Healthcare Trust (DHC) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
